HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M H Hofker Selected Research

Non-alcoholic Fatty Liver Disease

2/2015Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M H Hofker Research Topics

Disease

9Atherosclerosis
05/2014 - 01/2000
3Inflammation (Inflammations)
04/2017 - 05/2014
3Obesity
02/2015 - 05/2014
2Alcoholic Fatty Liver
04/2017 - 05/2014
2Fatty Liver
04/2017 - 08/2000
2Type 2 Diabetes Mellitus (MODY)
04/2009 - 01/2007
2Hyperlipoproteinemia Type III (Broad Beta Disease)
08/2000 - 07/2000
1Hepatitis
04/2017
1Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2017
1Non-alcoholic Fatty Liver Disease
02/2015
1Body Weight (Weight, Body)
02/2015
1Thinness
02/2015
1Metabolic Diseases (Metabolic Disease)
05/2014
1Cardiovascular Diseases (Cardiovascular Disease)
05/2014
1Insulin Resistance
04/2009
1Hyperglycemia
04/2009
1Disease Progression
04/2009
1Acute-Phase Reaction
12/2001
1Hypertriglyceridemia
07/2000
1Alzheimer Disease (Alzheimer's Disease)
01/2000
1Facioscapulohumeral Muscular Dystrophy
01/2000

Drug/Important Bio-Agent (IBA)

6Apolipoproteins E (ApoE)IBA
01/2001 - 01/2000
6ApolipoproteinsIBA
01/2001 - 01/2000
5CholesterolIBA
05/2014 - 01/2000
4Lipoproteins (Lipoprotein)IBA
12/2001 - 01/2000
4Scavenger Receptors (Scavenger Receptor)IBA
12/2000 - 01/2000
3Glucose (Dextrose)FDA LinkGeneric
02/2015 - 01/2007
2oxidized low density lipoproteinIBA
04/2017 - 02/2000
2LipidsIBA
04/2017 - 02/2000
2LDL Receptors (LDL Receptor)IBA
01/2001 - 09/2000
2Apolipoprotein E2IBA
07/2000 - 01/2000
1Insulin-Like PeptidesIBA
02/2015
1Insulin-Like Growth Factor I (IGF-1)IBA
02/2015
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2015
1Plasminogen InactivatorsIBA
02/2015
1Plasminogen Activator Inhibitor 1IBA
02/2015
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
02/2015
1LeptinIBA
02/2015
1Angiopoietin-2IBA
02/2015
1Chemokine CXCL10IBA
02/2015
1AdipokinesIBA
02/2015
1ChromatinIBA
02/2015
1Insulin (Novolin)FDA Link
02/2015
1Blood Glucose (Blood Sugar)IBA
04/2009
1Transcription Factors (Transcription Factor)IBA
01/2007
1LDL CholesterolIBA
01/2001
1Cholesterol Esters (Cholesteryl Esters)IBA
09/2000
1Protein Isoforms (Isoforms)IBA
08/2000
1VLDL LipoproteinsIBA
07/2000
1Triglycerides (Triacylglycerol)IBA
07/2000
1low density lipoprotein inhibitorIBA
02/2000
1LDL Lipoproteins (beta Lipoproteins)IBA
02/2000
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2000
1TubulinIBA
01/2000
1Apolipoprotein E3IBA
01/2000
1Proteins (Proteins, Gene)FDA Link
01/2000
1Cholinergic Agents (Cholinergics)IBA
01/2000

Therapy/Procedure

2Therapeutics
02/2015 - 04/2009
1Transplantation
12/2000
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2000